AI-generated summary
The authors describe a single 79-year-old woman with anal margin carcinoma who developed grade 2 radiation-induced epithelitis refractory to topical treatment. Red-light photobiomodulation at 632 nm was given, and the authors report rapid pain reduction, progressive healing, and no further skin toxicity after two sessions before re-irradiation. The authors state this is a single-patient case and that the findings are preliminary.
- Who or what was studied
- One 79-year-old woman with epidermoid carcinoma of the anal margin receiving chemoradiotherapy
- Wavelengths
- 632 nm
- Limits stated in the abstract
- Single-patient case report with findings the authors describe as preliminary, requiring confirmation in controlled clinical studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 632 nm
- Power density (irradiance)
- 67 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Near-infrared, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.